{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:51:39Z","timestamp":1782957099609,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0508702"],"award-info":[{"award-number":["2023ZD0508702"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["23JCYBJC00950"],"award-info":[{"award-number":["23JCYBJC00950"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Health Science and Technology Project key discipline special","award":["TJWJ2022XK034"],"award-info":[{"award-number":["TJWJ2022XK034"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]},{"name":"Research project in key areas of TCM in 2024","award":["2024022"],"award-info":[{"award-number":["2024022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11010-025-05231-0","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:05:53Z","timestamp":1740135953000},"page":"3907-3921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Olaparib reverses prostate cancer resistance to Rapamycin by promoting macrophage polarization towards the M1 phenotype"],"prefix":"10.1007","volume":"480","author":[{"given":"Kai","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiao","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"5231_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3760\/cma.j.cn112152-20211226-00975","volume":"44","author":"J He","year":"2022","unstructured":"He J, Chen WQ, Li N, Cao W, Ye DW, Ma JH, Xing NZ, Peng J, Tian JH (2022) China guideline for the screening and early detection of prostate cancer (2022, Beijing). Zhonghua Zhong Liu Za Zhi 44:29\u201353. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20211226-00975","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"5231_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-021-01315-9","volume":"20","author":"XD Yang","year":"2021","unstructured":"Yang XD, Kong FE, Qi L, Lin JX, Yan Q, Loong JHC, Xi SY, Zhao Y, Zhang Y, Yuan YF, Ma NF, Ma S, Guan XY, Liu M (2021) PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma. Mol Cancer 20:20. https:\/\/doi.org\/10.1186\/s12943-021-01315-9","journal-title":"Mol Cancer"},{"key":"5231_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s41419-022-05257-y","volume":"13","author":"S Tang","year":"2022","unstructured":"Tang S, Shen Y, Wei X, Shen Z, Lu W (2022) Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer. Cell Death Dis 13:826. https:\/\/doi.org\/10.1038\/s41419-022-05257-y","journal-title":"Cell Death Dis"},{"key":"5231_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.799428","volume":"12","author":"M Xiao","year":"2021","unstructured":"Xiao M, He J, Yin L, Chen X, Zu X, Shen Y (2021) Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer. Front Immunol 12:799428. https:\/\/doi.org\/10.3389\/fimmu.2021.799428","journal-title":"Front Immunol"},{"key":"5231_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40164-021-00252-z","volume":"10","author":"S Zhu","year":"2021","unstructured":"Zhu S, Yi M, Wu Y, Dong B, Wu K (2021) Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies. Exp Hematol Oncol 10:60. https:\/\/doi.org\/10.1186\/s40164-021-00252-z","journal-title":"Exp Hematol Oncol"},{"key":"5231_CR6","first-page":"5857","volume":"60","author":"S Shimura","year":"2000","unstructured":"Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A, Thompson TC (2000) Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 60:5857\u20135861","journal-title":"Cancer Res"},{"key":"5231_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X (2021) Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther 6:75. https:\/\/doi.org\/10.1038\/s41392-021-00484-9","journal-title":"Signal Transduct Target Ther"},{"key":"5231_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","volume":"6","author":"Z Duan","year":"2021","unstructured":"Duan Z, Luo Y (2021) Targeting macrophages in cancer immunotherapy. Signal Transduct Target Ther 6:127. https:\/\/doi.org\/10.1038\/s41392-021-00506-6","journal-title":"Signal Transduct Target Ther"},{"key":"5231_CR9","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","volume":"10","author":"Q Yang","year":"2020","unstructured":"Yang Q, Guo N, Zhou Y, Chen J, Wei Q, Han M (2020) The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy. Acta Pharm Sin B 10:2156\u20132170. https:\/\/doi.org\/10.1016\/j.apsb.2020.04.004","journal-title":"Acta Pharm Sin B"},{"key":"5231_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H (2019) Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol 12:76. https:\/\/doi.org\/10.1186\/s13045-019-0760-3","journal-title":"J Hematol Oncol"},{"key":"5231_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","volume":"41","author":"N Kumari","year":"2022","unstructured":"Kumari N, Choi SH (2022) Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies. J Exp Clin Cancer Res 41:68. https:\/\/doi.org\/10.1186\/s13046-022-02272-x","journal-title":"J Exp Clin Cancer Res"},{"key":"5231_CR12","doi-asserted-by":"publisher","first-page":"1026954","DOI":"10.3389\/fimmu.2022.1026954","volume":"13","author":"C Kerneur","year":"2022","unstructured":"Kerneur C, Cano CE, Olive D (2022) Major pathways involved in macrophage polarization in cancer. Front Immunol 13:1026954. https:\/\/doi.org\/10.3389\/fimmu.2022.1026954","journal-title":"Front Immunol"},{"key":"5231_CR13","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1158\/1078-0432.Ccr-10-0124","volume":"16","author":"AJ Armstrong","year":"2010","unstructured":"Armstrong AJ, Netto GJ, Rudek MA, Halabi S, Wood DP, Creel PA, Mundy K, Davis SL, Wang T, Albadine R, Schultz L, Partin AW, Jimeno A, Fedor H, Febbo PG, George DJ, Gurganus R, De Marzo AM, Carducci MA (2010) A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer. Clin Cancer Res 16:3057\u20133066. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-0124","journal-title":"Clin Cancer Res"},{"key":"5231_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3816\/CGC.2008.n.015","volume":"6","author":"RJ Amato","year":"2008","unstructured":"Amato RJ, Jac J, Mohammad T, Saxena S (2008) Pilot study of rapamycin in patients with hormone-refractory prostate cancer. Clin Genitourin Cancer 6:97\u2013102. https:\/\/doi.org\/10.3816\/CGC.2008.n.015","journal-title":"Clin Genitourin Cancer"},{"key":"5231_CR15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/cancers11070986","volume":"11","author":"MP Singh","year":"2019","unstructured":"Singh MP, Cho HJ, Kim JT, Baek KE, Lee HG, Kang SC (2019) Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1\/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma. Cancers (Basel) 11:986. https:\/\/doi.org\/10.3390\/cancers11070986","journal-title":"Cancers (Basel)"},{"key":"5231_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG (2020) Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21:85\u2013100. https:\/\/doi.org\/10.1038\/s41580-019-0173-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5231_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X (2022) The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol 15:129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8","journal-title":"J Hematol Oncol"},{"key":"5231_CR18","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I (2020) The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. Int J Mol Sci 21:9739. https:\/\/doi.org\/10.3390\/ijms21249739","journal-title":"Int J Mol Sci"},{"key":"5231_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F (2022) Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov 21:799\u2013820. https:\/\/doi.org\/10.1038\/s41573-022-00520-5","journal-title":"Nat Rev Drug Discov"},{"key":"5231_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-020-01808-3","volume":"40","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Han Q, Zhao H, Zhang J (2021) Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b\/\u03b2-catenin\/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res 40:13. https:\/\/doi.org\/10.1186\/s13046-020-01808-3","journal-title":"J Exp Clin Cancer Res"},{"key":"5231_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109955","volume":"37","author":"L He","year":"2021","unstructured":"He L, Jhong JH, Chen Q, Huang KY, Strittmatter K, Kreuzer J, DeRan M, Wu X, Lee TY, Slavov N, Haas W, Marneros AG (2021) Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors. Cell Rep 37:109955. https:\/\/doi.org\/10.1016\/j.celrep.2021.109955","journal-title":"Cell Rep"},{"key":"5231_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00395-020-0781-7","volume":"115","author":"S Liu","year":"2020","unstructured":"Liu S, Chen J, Shi J, Zhou W, Wang L, Fang W, Zhong Y, Chen X, Chen Y, Sabri A, Liu S (2020) M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment. Basic Res Cardiol 115:22. https:\/\/doi.org\/10.1007\/s00395-020-0781-7","journal-title":"Basic Res Cardiol"},{"key":"5231_CR23","doi-asserted-by":"publisher","unstructured":"Larionova I and Kazakova E (2021) New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13133253","DOI":"10.3390\/cancers13133253"},{"key":"5231_CR24","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1038\/s41467-021-23164-2","volume":"12","author":"YC Wang","year":"2021","unstructured":"Wang YC, Wang X, Yu J, Ma F (2021) Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat Commun 12:3530. https:\/\/doi.org\/10.1038\/s41467-021-23164-2","journal-title":"Nat Commun"},{"key":"5231_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41586-024-07217-2","volume":"628","author":"M Petropoulos","year":"2024","unstructured":"Petropoulos M, Karamichali A, Rossetti GG (2024) Transcription-replication conflicts underlie sensitivity to PARP inhibitors. Nature 628:433\u2013441. https:\/\/doi.org\/10.1038\/s41586-024-07217-2","journal-title":"Nature"},{"key":"5231_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s12276-021-00557-3","volume":"53","author":"DS Kim","year":"2021","unstructured":"Kim DS, Camacho CV, Kraus WL (2021) Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance. Exp Mol Med 53:42\u201351. https:\/\/doi.org\/10.1038\/s12276-021-00557-3","journal-title":"Exp Mol Med"},{"key":"5231_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/14728222.2023.2230362","volume":"27","author":"SS Badve","year":"2023","unstructured":"Badve SS, G\u00f6kmen-Polar Y (2023) Targeting the Tumor-Tumor Microenvironment Crosstalk. Expert Opin Ther Targets 27:447\u2013457. https:\/\/doi.org\/10.1080\/14728222.2023.2230362","journal-title":"Expert Opin Ther Targets"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05231-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05231-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05231-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:03:00Z","timestamp":1747904580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05231-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5231"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05231-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5399970\/v1","asserted-by":"object"}]},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}